APIs and Excipients

Alcami in API Manufacturing Pact with Solasia

November 13, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Alcami will manufacture clinical supply of the API for a drug candidate targeting various hematologics and solid cancers.

AstraZeneca Gets Positive EMA Opinion on Respiratory Biologic

November 10, 2017

The EMA’s Committee for Medicinal Products for Human Use has recommended marketing authorization approval for AstraZeneca’s benralizumab, a monoclonal antibody for treating severe asthma.

Dynavax Wins FDA Approval for Hep B Vaccine

November 10, 2017

The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.

Celonic Acquires Glycotope’s Biomanufacturing Facility

November 03, 2017

CDMO Celonic acquired a biomanufacturing facility in Heidelberg, Germany from Glycotope.

Catalent and Grid Therapeutics Form Immuno-Oncology Pact

November 02, 2017

The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.

Awards Recognize Industry Contributions

November 02, 2017

Industry experts were honored for business, scientific, and social contributions.

Growing Demand for Taste-Masking Technologies

November 02, 2017

Taste masking increases drug acceptability and medication adherence in pediatric, geriatric, and other special patient populations.

PTSM: Pharmaceutical Technology Sourcing and Management